TD Cowen raises target for HCA Healthcare stock from USD 431 to USD 460

Published on 10/26/2026 at 11:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

TD Cowen raised its target from USD 431 to USD 460 on October 12, 2026. HCA Healthcare stock costs EUR 419.25 on October 26, 2026.

Analyst view and reporting date

TD Cowen raised its target from USD 431 to USD 460 on October 12, 2026.
HCA Healthcare reported USD 20.23 billion in revenue for its latest reported quarter, up 8.70 percent year over year.
HCA Healthcare stock trades at EUR 419.25 at 11:21 a.m. CEST at Lang & Schwarz on October 26, 2026.

Belebter NYSE-Handelssaal mit Tradern, großen Monitoren und Kursdiagrammen des Healthcare-Sektors — HCA Healthcare US40412C1018 NYSE Handelsparkett mit Händlern und Healthcare Sektor Charts auf großen Bildschirmen, Illustration mit AI erstellt.

HCA Healthcare (ISIN US40412C1018) was trading at EUR 419.25 at Lang & Schwarz on October 26, 2026, at 11:21 a.m. CEST. Markets Insider reported that TD Cowen raised its HCA Healthcare target from USD 431 to USD 460 on October 12, 2026, while keeping a Buy rating.

Target rises before results

The revision came ahead of HCA Healthcare's third-quarter report. TD Cowen lowered its third-quarter adjusted EBITDA estimate because of weaker hospital survey results, while lifting its fourth-quarter estimate on anticipated cost reductions, according to the same October 12 report from Markets Insider.

What does the target revision imply?

The latest operating base was substantial. HCA Healthcare generated USD 20.23 billion in revenue in the second quarter of 2026, an increase of 8.70 percent from the same quarter a year earlier, according to Yahoo Finance. The company therefore enters the report with a clear growth comparison, but the analyst note also points to survey data and cost control as important profit variables.

Three dates frame the report

On July 24, 2026, HCA Healthcare reported quarterly revenue of USD 20.23 billion, up 8.70 percent year over year, according to MarketBeat. On October 12, 2026, TD Cowen lifted its target from USD 431 to USD 460. The current event is scheduled for October 27, 2026, when HCA Healthcare will host its third-quarter earnings call at 10:00 a.m. ET, as stated by HCA Healthcare.

Reporting date is October 27

The next scheduled date is October 27, 2026, for the third-quarter earnings call. The company identifies itself as NYSE-listed under ticker HCA, and the upcoming release will test whether the 8.70 percent revenue growth from the second quarter carried into the latest period.

Price remains the market anchor

On the NYSE, HCA Healthcare was last quoted at USD 469.03 on October 23, 2026, at 4:00 p.m. ET. The euro reference price was EUR 419.25 at Lang & Schwarz on October 26, 2026, at 11:21 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of HCA Healthcare stock.